These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A practical guide to the management and prevention of migraine. Diener HC; Kaube H; Limmroth V Drugs; 1998 Nov; 56(5):811-24. PubMed ID: 9829155 [TBL] [Abstract][Full Text] [Related]
23. Novel Therapies in Acute Migraine Management: Small-Molecule Calcitonin Gene-Receptor Antagonists and Serotonin 1F Receptor Agonist. Joyner KR; Morgan KW Ann Pharmacother; 2021 Jun; 55(6):745-759. PubMed ID: 32993366 [TBL] [Abstract][Full Text] [Related]
24. Canadian Headache Society Guideline: acute drug therapy for migraine headache. Worthington I; Pringsheim T; Gawel MJ; Gladstone J; Cooper P; Dilli E; Aube M; Leroux E; Becker WJ; Can J Neurol Sci; 2013 Sep; 40(5 Suppl 3):S1-S80. PubMed ID: 23968886 [TBL] [Abstract][Full Text] [Related]
25. Drugs for the acute treatment of migraine in children and adolescents. Richer L; Billinghurst L; Linsdell MA; Russell K; Vandermeer B; Crumley ET; Durec T; Klassen TP; Hartling L Cochrane Database Syst Rev; 2016 Apr; 4(4):CD005220. PubMed ID: 27091010 [TBL] [Abstract][Full Text] [Related]
26. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Tfelt-Hansen P; De Vries P; Saxena PR Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011 [TBL] [Abstract][Full Text] [Related]
27. [Pharmacotherapy of headache with special reference to migraine]. Beubler E Wien Med Wochenschr; 1994; 144(5-6):100-1. PubMed ID: 8053212 [TBL] [Abstract][Full Text] [Related]
30. Eletriptan: a review of its use in the acute treatment of migraine. McCormack PL; Keating GM Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799 [TBL] [Abstract][Full Text] [Related]
31. Spotlight on rizatriptan in migraine. Wellington K; Jarvis B CNS Drugs; 2002; 16(10):715-20. PubMed ID: 12269863 [TBL] [Abstract][Full Text] [Related]
32. Rizatriptan: an update of its use in the management of migraine. Wellington K; Plosker GL Drugs; 2002; 62(10):1539-74. PubMed ID: 12093318 [TBL] [Abstract][Full Text] [Related]
33. Information on migraine drugs in commonly available Indian drug information sources - Whether we satisfied the community needs? Thangaraju P; Mahesh K; Venkatesan S Indian J Pharmacol; 2022; 54(3):216-220. PubMed ID: 35848693 [TBL] [Abstract][Full Text] [Related]
34. In brief: Erenumab (Aimovig) hypersensitivity. Med Lett Drugs Ther; 2019 Mar; 61(1568):48. PubMed ID: 31022159 [No Abstract] [Full Text] [Related]
35. Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans. de Vries T; Villalón CM; MaassenVanDenBrink A Pharmacol Ther; 2020 Jul; 211():107528. PubMed ID: 32173558 [TBL] [Abstract][Full Text] [Related]
36. Migraine: diagnosis and management. Goadsby PJ Intern Med J; 2003; 33(9-10):436-42. PubMed ID: 14511196 [TBL] [Abstract][Full Text] [Related]
37. Migraine in pregnancy: what are the safest treatment options? Pfaffenrath V; Rehm M Drug Saf; 1998 Nov; 19(5):383-8. PubMed ID: 9825951 [TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine. Zhang L; Hay JW CNS Drugs; 2005; 19(7):635-42. PubMed ID: 15984898 [TBL] [Abstract][Full Text] [Related]